Efflux pumps as antimicrobial resistance mechanisms
- PMID: 17457715
- DOI: 10.1080/07853890701195262
Efflux pumps as antimicrobial resistance mechanisms
Abstract
Antibiotic resistance continues to hamper antimicrobial chemotherapy of infectious disease, and while biocide resistance outside of the laboratory is as yet unrealized, in vitro and in vivo episodes of reduced biocide susceptibility are not uncommon. Efflux mechanisms, both drug-specific and multidrug, are important determinants of intrinsic and/or acquired resistance to these antimicrobials in important human pathogens. Multidrug efflux mechanisms are generally chromosome-encoded, with their expression typically resultant from mutations in regulatory genes, while drug-specific efflux mechanisms are encoded by mobile genetic elements whose acquisition is sufficient for resistance. While it has been suggested that drug-specific efflux systems originated from efflux determinants of self-protection in antibiotic-producing Actinomycetes, chromosomal multidrug efflux determinants, at least in Gram-negative bacteria, are appreciated as having an intended housekeeping function unrelated to drug export and resistance. Thus, it will be important to elucidate the intended natural function of these efflux mechanisms in order, for example, to anticipate environmental conditions or circumstances that might promote their expression and, so, compromise antimicrobial chemotherapy. Given the clinical significance of antimicrobial exporters, it is clear that efflux must be considered in formulating strategies for treatment of drug-resistant infections, both in the development of new agents, for example, less impacted by efflux or in targeting efflux directly with efflux inhibitors.
Similar articles
-
Efflux-mediated antimicrobial resistance.J Antimicrob Chemother. 2005 Jul;56(1):20-51. doi: 10.1093/jac/dki171. Epub 2005 May 24. J Antimicrob Chemother. 2005. PMID: 15914491 Review.
-
Mechanisms of bacterial biocide and antibiotic resistance.J Appl Microbiol. 2002;92 Suppl:55S-64S. J Appl Microbiol. 2002. PMID: 12000613 Review.
-
Mechanisms of bacterial biocide and antibiotic resistance.Symp Ser Soc Appl Microbiol. 2002;(31):55S-64S. Symp Ser Soc Appl Microbiol. 2002. PMID: 12481829 Review.
-
[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].Mikrobiyol Bul. 2007 Apr;41(2):309-27. Mikrobiyol Bul. 2007. PMID: 17682720 Review. Turkish.
-
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?J Appl Microbiol. 2002;92 Suppl:98S-110S. J Appl Microbiol. 2002. PMID: 12000619 Review.
Cited by
-
The ins and outs of RND efflux pumps in Escherichia coli.Front Microbiol. 2015 Jun 10;6:587. doi: 10.3389/fmicb.2015.00587. eCollection 2015. Front Microbiol. 2015. PMID: 26113845 Free PMC article. Review.
-
The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo.Int J Mol Sci. 2013 Jan 16;14(1):1802-21. doi: 10.3390/ijms14011802. Int J Mol Sci. 2013. PMID: 23325048 Free PMC article.
-
Study of the multidrug membrane transporter of single living Pseudomonas aeruginosa cells using size-dependent plasmonic nanoparticle optical probes.Biochemistry. 2010 Jul 20;49(28):5942-53. doi: 10.1021/bi100268k. Biochemistry. 2010. PMID: 20540528 Free PMC article.
-
Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli.BMC Microbiol. 2019 Aug 22;19(1):195. doi: 10.1186/s12866-019-1561-0. BMC Microbiol. 2019. PMID: 31438868 Free PMC article.
-
The role of gut microbiota in the development of colorectal cancer: a review.Int J Colorectal Dis. 2022 Jul;37(7):1509-1523. doi: 10.1007/s00384-022-04192-w. Epub 2022 Jun 15. Int J Colorectal Dis. 2022. PMID: 35704091 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical